Abigail Langsam has represented clients in a host of patent litigations, spanning technologies including traditional pharmaceuticals, biotechnology, semiconductors and computer systems. Additionally, Ms. Langsam has represented clients in connection with complex commercial litigations. She has worked closely with clients at all stages of litigation, and has considerable experience in discovery, including depositions and work with technical experts, trial preparation, and brief-writing.
- IP Team Advises Novartis on Series of Strategic Transactions Worth $30 Billion April 24, 2014
- Kaye Scholer Obtains Complete Victory for CLS Bank in Major Business Method and System – Patent Litigation Confronting Bilski-Related Issues March 24, 2011
- Firm Lawyers Honored as Empire State Counsel by New York State Bar Association January 28, 2010